Triptans for treatment of acute pediatric migraine: A systematic literature review

Pediatric Neurology

Volumn 29, Issue 5, 2003, Pages 425-429

  Major, Paul W ^a   Grubisa, Helen S I ^b   Thie, Norman M R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NARATRIPTAN; PHENYTOIN; PROPRANOLOL DERIVATIVE; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

ACUTE DISEASE; ASTHENIA; CHILDHOOD DISEASE; CLINICAL TRIAL; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MEDLINE; MIGRAINE; MYOCLONUS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SIDE EFFECT; TASTE DISORDER; THROAT DISEASE; TREATMENT FAILURE; XEROSTOMIA;

EID: 0346995456     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(03)00400-4     Document Type: Review

References (25)

1. Rasmussen B.K., Jensen R., Schroll M., Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol. 44:1991;1147-1157.
2. Lee L.H., Olness K.N. Clinical and demographic characteristics of migraine in urban children. Headache. 37:1997;269-276.
3. Abu-Arefeh I., Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 309:1994;765-769.
4. Bille B. Migraine in schoolchildren. Acta Paediatrica. 51:(Suppl. 136):1962;1-151.
5. Metsähonkala L., Sillanpää M., Tuominen J. Use of health care services in childhood migraine. Headache. 36:1996;423-428.
6. Winner P., Wasiewski W., Gladstein J., Linder S. Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Pediatric Headache Committee of the American Association for the Study of Headache. Headache. 37:1997;545-548.
7. Wöber-Bingöl C., Wöber C., Wagner-Ennsgraber C., et al. IHS criteria for migraine and tension-type headache in children and adolescents. Headache. 36:1996;231-238.
8. Lewis D.W., Middlebrook M.T., Mehallick L., Rauch T.M., Deline C., Thomas E.F. Pediatric headaches What do the children want? Headache. 36:1996;224-230.
9. Silverboard G. Childhood migraine: A practical review. Medscape Neurology [serial online] 2001 [cited February 2002];3(1):[14 screens]. Available from URL: http://www.medscape.com/px/urlinfo.
10. Hermann C., Kim M., Blanchard E.B. Behavioral and prophylactic pharmacological intervention studies of pediatric migraine An exploratory meta-analysis . Pain. 60:1995;239-255.
11. Bulloch B., Tenenbein M. Emergency department management of pediatric migraine. Pediatr Emerg Care. 16:2000;196-201.
12. Graf W.D., Riback P.S. Pharmacologic treatment of recurrent pediatric headache. Pediatr Ann. 24:1995;477-484.
13. Hämäläinen M.L., Hoppu K., Santavuori P. Sumatriptan for migraine attacks in children A randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology. 48:1997;1100-1103.
14. Ueberall M.A., Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 52:1999;1507-1510.
15. Winner P., Rothner A.D., Saper J., et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 106:2000;989-997.
16. Winner P., Lewis D., Visser W.H., Jiang K., Ahrens S., Evans J.K. Rizatriptan 5 mg for the acute treatment of migraine in adolescents A randomized, double-blind, placebo-controlled study . Headache. 42:2002;49-55.
17. MacDonald J.T. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 34:1994;581-582.
18. Linder S.L. Subcutaneous sumatriptan in the clinical setting The first 50 consecutive patients with acute migraine in a pediatric neurology office practice . Headache. 36:1996;419-422.
19. Rothner A.D., Winner P., Nett R., et al. One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine Results of a multicenter, open-label study . Clin Ther. 22:2000;1533-1546.
20. Linder S.L., Dowson A.J. Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Pract. 54:2000;466-469.
21. Dixon R., Engleman K., Kemp J., Ruckle J.L. A comparison of the pharmacokinetics and tolerability of the novel antimigraine compound zolmitriptan in adolescents and adults. J Child Adolesc Psychopharmacol. 9:1999;35-42.
22. Christensen M.L., Eades S.K., Fuseau E., Kempsford R.D., Phelps S.J., Hak L.J. Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine. J Clin Pharmacol. 41:2001;170-175.
23. Winner P., Sadowski C., Pate D. Pharmacokinetics of rizatriptan in adolescent migraineurs. Headache. 38:1998;411.
24. Aaltonen K., Hamalainen M.L., Hoppu K. Children's response to placebo from migraine attacks. Cephalalgia. 20:2000;284.
25. Geraud G., Olesen J., Pfaffenrath V., et al. Comparison of the efficacy of zolmitriptan and sumatriptan Issues in migraine trial design . Cephalalgia. 20:2000;30-38.